Tuesday, November 24, 2009, 5:04am EST - Canadian Markets open in 4 hours and 26 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Achillion Pharmaceuticals, Inc. (ACHN)

 On Nov 23: 1.8699 USD   0.00 (0.00%)  
MORE ON ACHN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Achillion Pharmaceuticals, Inc. (NGM:ACHN) Delayed quote dataEdit
Last Trade: 1.8699 USD
Trade Time: Nov 23
Change: 0.00 (0.00%)
Prev Close: 1.8699
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 4.50
Day's Range: N/A - N/A
52wk Range: 0.65 - 2.42
Volume: 0
Avg Vol (3m): 32,780
Market Cap: 49.84M
P/E (ttm): N/A
EPS (ttm): -1.053
Div & Yield: N/A (N/A%)
Achillion Pharmaceuticals, Inc. (ACHN)
1d  5d  3m  6m  1y  2y  5y 
 Add ACHN to Portfolio   Download Data

HEADLINES
• ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule
EDGAR Online (Tue, Nov 17)
• New Star Analyst Rankings for Achillion Pharmaceuticals, Inc.
StarMine (Tue, Nov 10)
• Morningstar Strategist Says Healthcare Bill Will Be Law By End Of Year: Is Your Portfolio Ready?
Wall Street Transcript (Mon, Nov 9)
• ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Fri, Nov 6)
• Coverage initiated on Achillion Pharma by Wedbush Morgan
Briefing.com (Wed, Oct 21)
• ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Fri, Sep 4)
• ACHILLION PHARMACEUTICALS INC Financials
EDGAR Online Financials (Thu, Aug 6)
• ACHILLION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Aug 3)
• ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online (Thu, Jul 30)
• ACHILLION PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
EDGAR Online (Mon, Jul 6)
More Headlines for ACHN...
ANALYST
EPS Est (next year) (Dec-09) : -0.94
EPS Est (in 2 years) (Dec-10) : -0.62
Avg Rec (current)*: 2.4
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices